We are live on ! Find out more
MRCM

M&R Capital Management Portfolio holdings

AUM $454M
1-Year Est. Return 40.11%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+40.11%
3 Year Est. Return
+52.56%
5 Year Est. Return
+141.03%
10 Year Est. Return
+275.44%
AUM
$419M
AUM Growth
+$10.9M
Cap. Flow
+$2.31M
Cap. Flow %
0.55%
Top 10 Hldgs %
47.82%
Holding
559
New
11
Increased
126
Reduced
102
Closed
12

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$8.37M
2
CACI icon
CACI
CACI
+$5.74M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$2.32M
4
PEP icon
PepsiCo
PEP
+$1.38M
5
ACGL icon
Arch Capital
ACGL
+$1.25M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$8.98M
2
CMCSA icon
Comcast
CMCSA
+$2.47M
3
LW icon
Lamb Weston
LW
+$2.32M
4
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$1.3M
5
MMM icon
3M
MMM
+$1.04M

Sector Composition

Rank Sector Weight
1 Technology 27.36%
2 Financials 20.03%
3 Healthcare 10.65%
4 Communication Services 9.1%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLI icon
501
State Street Industrial Select Sector SPDR ETF
XLI
$32.9B
$1.46K ﹤0.01%
12
XLY icon
502
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.1B
$1.46K ﹤0.01%
16
ALTO icon
503
Alto Ingredients
ALTO
$316M
$1.45K ﹤0.01%
1,000
IVW icon
504
iShares S&P 500 Growth ETF
IVW
$76.8B
$1.39K ﹤0.01%
15
WWW icon
505
Wolverine World Wide
WWW
$1.67B
$1.35K ﹤0.01%
100
IJK icon
506
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$1.32K ﹤0.01%
15
IHF icon
507
iShares US Healthcare Providers ETF
IHF
$1.23B
$1.31K ﹤0.01%
25
IJT icon
508
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.08B
$1.28K ﹤0.01%
10
RSPF icon
509
Invesco S&P 500 Equal Weight Financials ETF
RSPF
$316M
$1.23K ﹤0.01%
20
LEG icon
510
Leggett & Platt
LEG
$1.15K ﹤0.01%
100
-41
-29% -$579
BFK
511
DELISTED
BlackRock Municipal Income Trust
BFK
$1.14K ﹤0.01%
112
IJJ icon
512
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$1.14K ﹤0.01%
10
EEM icon
513
iShares MSCI Emerging Markets ETF
EEM
$31.2B
$1.06K ﹤0.01%
25
-165
-87% -$6.92K
BF.B icon
514
Brown-Forman Class B
BF.B
$12.5B
$993 ﹤0.01%
23
EMO
515
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.11B
$989 ﹤0.01%
24
-176
-88% -$7.29K
ODD icon
516
ODDITY Tech
ODD
$662M
$982 ﹤0.01%
25
HOG icon
517
Harley-Davidson
HOG
$2.92B
$839 ﹤0.01%
25
MTB icon
518
M&T Bank
MTB
$34.3B
$757 ﹤0.01%
5
OXY.WS icon
519
Occidental Petroleum Corp Warrants
OXY.WS
$34.9B
$741 ﹤0.01%
18
VTRS icon
520
Viatris
VTRS
$18.8B
$723 ﹤0.01%
68
F icon
521
Ford
F
$55.3B
$690 ﹤0.01%
55
POR icon
522
Portland General Electric
POR
$5.83B
$649 ﹤0.01%
15
SHYG icon
523
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.68B
$633 ﹤0.01%
15
-200
-93% -$8.42K
SOCL icon
524
Global X Social Media ETF
SOCL
$89.9M
$633 ﹤0.01%
15
SBRA icon
525
Sabra Healthcare REIT
SBRA
$5.27B
$631 ﹤0.01%
41

Similar funds

M&R Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, M&R Capital Management held 559 positions worth $419M, up 2.7% from $408M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.1%. M&R Capital Management opened 11 new positions and exited 12, leaving the 559-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • M&R Capital Management's largest Q2 2024 buy was KeyCorp: 11,973 shares worth $170K.
  • M&R Capital Management added most to AstraZeneca in Q2 2024, an estimated $8.37M increase.
  • M&R Capital Management's biggest Q2 2024 reduction was CVS Health, cutting an estimated $8.98M.
  • M&R Capital Management fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $42.7K.
  • M&R Capital Management's ten largest holdings make up 48% of its $419M portfolio in Q2 2024.
  • M&R Capital Management opened 11 new positions and closed 12 in Q2 2024.
  • M&R Capital Management's portfolio value rose 2.7% quarter-over-quarter to $419M.

Based on M&R Capital Management's 13F filing for Q2 2024, filed 2 Jul 2024.